Effect of Octreotide on experimental corneal neovascularization


Demir T., CELIKER U., KUKNER A., MOGULKOC R., CELEBI S., CELIKER H.

ACTA OPHTHALMOLOGICA SCANDINAVICA, vol.77, no.4, pp.386-390, 1999 (SCI-Expanded) identifier identifier identifier

Abstract

Purpose:To examine the ability of subcutaneously administered Octreotide ( a long acting somatostatin analogue) to serve as an inhibitory agent for corneal neovascularization in eyes of Wistar Albino rats.